Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Eculizumab by Alexion Pharmaceuticals for Subarachnoid Hemorrhage: Likelihood of Approval
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Subarachnoid Hemorrhage. According to GlobalData, Phase...